Seven & i Holdings (3382) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
19 Jan, 2026Executive summary
Full-year financial forecasts were revised downward after underperformance in both domestic and overseas convenience store businesses and macroeconomic headwinds.
Strategic acceleration of business reforms, including divestment of unprofitable assets, group structure optimization, and focus on core CVS operations, is underway.
Major acquisitions in Australia and the U.S. expanded the global store network and contributed to asset growth.
Financial highlights
First half operating revenues reached ¥6,035.5 billion, up 8.8% year-over-year, but operating income fell to ¥186.9 billion (down 22.4% YoY), and net income dropped to ¥52.2 billion (down 34.9% YoY).
EBITDA for 1H was ¥471.5 billion, down 5% YoY.
Special losses in 1H totaled ¥86.2 billion, mainly from business withdrawals and restructuring.
Interim dividend maintained at ¥20 per share, with full-year forecast at ¥40 per share.
Outlook and guidance
Full-year operating revenue forecast revised upward to ¥11,879.0 billion (up 3.5% YoY), but operating profit and net profit revised downward to ¥403.0 billion (down 24.6% YoY) and ¥163.0 billion (down 27.4% YoY), respectively.
Effects of new measures expected to be limited in the current fiscal year, with growth targeted for FY2025 and beyond.
Annual dividend forecast is ¥40.00 per share post-share split.
Latest events from Seven & i Holdings
- Revenue up, profits down as acquisitions and inflation reshape global strategy.3382
Q1 20253 Feb 2026 - Profits and EPS soared on special gains and buybacks, with full-year outlook raised.3382
Q3 20262 Feb 2026 - Revenue up, profit down sharply; reforms and overseas expansion set stage for 2025 growth.3382
Q3 202510 Jan 2026 - Net income set to surge as reforms, buybacks, and SEI IPO drive future growth.3382
Q4 202520 Dec 2025 - Aggressive global expansion, digital innovation, and capital discipline drive 2030 growth targets.3382
Investor Day 202517 Dec 2025 - Net income more than doubled on asset sales and cost controls amid major business divestitures.3382
Q2 202613 Nov 2025 - Net income surged 229% YoY on asset sales, with portfolio reforms and guidance maintained.3382
Q1 20267 Nov 2025